Roughly 4% of the global population lives with an anxiety disorder at any given time, making it the most common mental health condition worldwide. That translates to more than 300 million people, and the number has been climbing steadily for decades.
Global Prevalence by the Numbers
The Global Burden of Disease study, which tracks health data across 204 countries and territories, provides the most comprehensive picture. Prevalence varies enormously by location. In 2021, Portugal had the highest age-standardized prevalence rate at about 9,712 cases per 100,000 people, meaning close to 1 in 10 people there met criteria for an anxiety disorder. At the low end, some regions in East Asia reported rates around 2,257 per 100,000, or roughly 2.3%.
These numbers capture people who meet the clinical threshold for a diagnosable anxiety disorder, including generalized anxiety, social anxiety, panic disorder, and specific phobias. They don’t account for the much larger number of people who experience significant anxiety symptoms without meeting the full diagnostic criteria.
Where Anxiety Is Most and Least Common
Anxiety disorders are not evenly distributed around the world. South America, North America, Europe, and Oceania consistently report higher prevalence than Asia and Africa. Countries with higher levels of socioeconomic development tend to report more anxiety, which likely reflects a combination of factors: better screening and diagnosis, different lifestyle stressors, and greater willingness to report mental health symptoms in surveys.
That doesn’t mean people in lower-income countries experience less distress. It often means anxiety goes unrecognized, unreported, or categorized differently. In many regions, mental health infrastructure barely exists, so prevalence data may significantly undercount the true burden.
How Rates Differ by Age
Anxiety disorders are the most common mental health condition among adolescents. According to the WHO, about 4.1% of children aged 10 to 14 and 5.3% of those aged 15 to 19 experience an anxiety disorder. The prevalence generally increases through adolescence and peaks during working-age adulthood, when career pressure, financial stress, and caregiving responsibilities converge.
Women and girls are diagnosed with anxiety disorders at roughly twice the rate of men and boys across nearly every country studied. This gap appears as early as adolescence and persists throughout life. Biological factors like hormonal fluctuations play a role, but so do social determinants: women are more likely to face economic insecurity, gender-based violence, and caregiving burdens that elevate chronic stress.
The COVID-19 Surge
The pandemic caused a sharp and well-documented spike. In the first year of COVID-19, global prevalence of anxiety and depression increased by 25%, according to the WHO. Lockdowns, social isolation, fear of illness, grief, and financial instability all contributed. Young people and women were disproportionately affected.
By the end of 2021, the situation had improved somewhat, but rates did not snap back to pre-pandemic levels. Projections from the Global Burden of Disease study suggest the number of people affected by anxiety disorders could reach roughly 87 million by 2050, reflecting both population growth and a long-term upward trend that predates the pandemic.
Most People With Anxiety Never Get Treatment
Perhaps the most striking statistic isn’t how many people have anxiety, but how few receive help. A large study spanning 21 countries found that among people who met criteria for an anxiety disorder in a given year, only about 28% received any treatment at all. Just 1 in 10 received what researchers considered “possibly adequate” treatment, meaning care that met minimum standards for duration and type.
Part of the problem is recognition. Fewer than half of people with a diagnosable anxiety disorder, roughly 41%, even perceived that they needed care. Many people normalize their symptoms, viewing chronic worry or avoidance as personality traits rather than treatable conditions. Others face practical barriers: cost, stigma, long wait times, or simply not having a mental health provider within reach. In low-income countries, there may be fewer than one psychiatrist per 100,000 people.
This treatment gap carries a real economic cost. Depression and anxiety together cost the global economy an estimated $1 trillion per year in lost productivity, according to the WHO. That figure includes absenteeism, reduced performance at work, and the downstream effects on physical health, since untreated anxiety is linked to higher rates of cardiovascular disease, chronic pain, and substance use.
What Drives the Global Rise
Anxiety disorder prevalence has been trending upward since at least the 1990s, well before COVID-19. Several forces are behind the increase. Urbanization concentrates people in environments with more noise, crowding, and social comparison. Economic inequality has widened in most countries, creating chronic financial uncertainty for a growing share of the population. Digital connectivity, while beneficial in many ways, exposes people to a constant stream of distressing news and social comparison, particularly adolescents.
Better awareness and diagnosis also play a role. As mental health literacy improves, more people recognize their symptoms and seek help, which increases reported prevalence even if the underlying rate hasn’t changed as dramatically. Disentangling “more people are anxious” from “more people are being counted” is one of the central challenges in global mental health research. Both are almost certainly happening simultaneously.